Sleep apnea syndrome in patients with cerebrovascular disease
Not Applicable
- Conditions
- Cerebrovascular disease
- Registration Number
- JPRN-UMIN000003411
- Lead Sponsor
- Stroke Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 800
Inclusion Criteria
Not provided
Exclusion Criteria
patients with poor respiratory status
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The presence of sleep apnea syndrome and associated factor in acute phase (from onset to 7days) of cerebrovascular disease. Short or long-term (at discharge and two years after) prognosis after treatment for sleep apnea syndrome
- Secondary Outcome Measures
Name Time Method